RU2002118730A - DRUG FOR LOCAL USE IN TREATMENT OF TUBERCULOSIS OF PULMONARY AND PURULENT INFLAMMATORY DISEASES - Google Patents

DRUG FOR LOCAL USE IN TREATMENT OF TUBERCULOSIS OF PULMONARY AND PURULENT INFLAMMATORY DISEASES

Info

Publication number
RU2002118730A
RU2002118730A RU2002118730/15A RU2002118730A RU2002118730A RU 2002118730 A RU2002118730 A RU 2002118730A RU 2002118730/15 A RU2002118730/15 A RU 2002118730/15A RU 2002118730 A RU2002118730 A RU 2002118730A RU 2002118730 A RU2002118730 A RU 2002118730A
Authority
RU
Russia
Prior art keywords
treatment
inflammatory diseases
phospholipids
tuberculosis
pulmonary
Prior art date
Application number
RU2002118730/15A
Other languages
Russian (ru)
Other versions
RU2217128C1 (en
Inventor
Галина Моисеевна Сорокоумова
Алла Анатольевна Селищева
Зульфира Хусаиновна Корнилова
Original Assignee
Закрытое акционерное общество "АИП-Наука"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "АИП-Наука" filed Critical Закрытое акционерное общество "АИП-Наука"
Priority to RU2002118730/15A priority Critical patent/RU2217128C1/en
Application granted granted Critical
Publication of RU2217128C1 publication Critical patent/RU2217128C1/en
Publication of RU2002118730A publication Critical patent/RU2002118730A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

1. Препарат для местного применения при лечении туберкулеза легких и гнойно-воспалительных заболеваний, представляющий собой рифампицин в липосомальной форме, содержащий рифампицин, фосфолипиды и водный компонент, отличающийся тем, что он дополнительно содержит аскорбиновую кислоту и α-токоферол, а в качестве водного компонента - изотонический раствор NaCl, при следующем соотношении компонентов, мас.%:1. A topical preparation for the treatment of pulmonary tuberculosis and purulent-inflammatory diseases, which is rifampicin in liposomal form, containing rifampicin, phospholipids and an aqueous component, characterized in that it additionally contains ascorbic acid and α-tocopherol, and as an aqueous component - isotonic NaCl solution, in the following ratio of components, wt.%: Рифампицин 0,5-2,0Rifampicin 0.5-2.0 Фосфолипиды 2,0-30,0Phospholipids 2.0-30.0 Аскорбиновая кислота 0,005-0,05Ascorbic acid 0.005-0.05 α-Токоферол 0,01-0,1α-Tocopherol 0.01-0.1 Изотонический раствор NaCl ОстальноеIsotonic NaCl solution 2. Препарат по п.1, отличающийся тем, что в качестве фосфолипидов он содержит смесь, содержащую, мас.%: фосфатидилхолин 70-80, остальное - холестерин или смесь других фосфолипидов животного и/или растительного происхождения, взятых в любом сочетании и соотношении.2. The drug according to claim 1, characterized in that as phospholipids it contains a mixture containing, wt.%: Phosphatidylcholine 70-80, the rest is cholesterol or a mixture of other phospholipids of animal and / or vegetable origin, taken in any combination and ratio .
RU2002118730/15A 2002-07-16 2002-07-16 Preparation for topical application in treatment of pulmonary tuberculosis and suppurative-inflammatory diseases RU2217128C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002118730/15A RU2217128C1 (en) 2002-07-16 2002-07-16 Preparation for topical application in treatment of pulmonary tuberculosis and suppurative-inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002118730/15A RU2217128C1 (en) 2002-07-16 2002-07-16 Preparation for topical application in treatment of pulmonary tuberculosis and suppurative-inflammatory diseases

Publications (2)

Publication Number Publication Date
RU2217128C1 RU2217128C1 (en) 2003-11-27
RU2002118730A true RU2002118730A (en) 2004-02-27

Family

ID=32028100

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002118730/15A RU2217128C1 (en) 2002-07-16 2002-07-16 Preparation for topical application in treatment of pulmonary tuberculosis and suppurative-inflammatory diseases

Country Status (1)

Country Link
RU (1) RU2217128C1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005107741A1 (en) * 2004-05-07 2005-11-17 Vinay Ramakant Sapte Novel oral compositions comprising antitubercular drugs in combination with alpha-tocopherol
WO2005107740A1 (en) * 2004-05-07 2005-11-17 Vinay Ramakant Sapte Enhancing the efficacy of tubercular drugs by combination with alpha tocopherol
RU2315593C1 (en) 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Antioxidant liposomal composition fir inhalation in lung and upper respiratory tract diseases
CH702736B1 (en) * 2008-12-31 2012-12-14 Obschestvo S Organichennoi Otvetstvennostju Scient Company Flamena Phospholipid emulsion which includes Dihydroquerzetin.
RU2469706C2 (en) * 2010-01-29 2012-12-20 Общество с ограниченной ответственностью "ВИРУД РУС" Pharmaceutical composition for transdermal application for increase of drug activity and decrease of side effects

Also Published As

Publication number Publication date
RU2217128C1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
DE60109938D1 (en) COMPOSITIONS THE ACTIVE STYLENEOID COMPOUNDS CONTAINED IN REDUCING THE TRIGLYCERID MIRROR
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
UY33494A (en) NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO20064186L (en) Substituted pyrazoline compositions to reduce blood triglycerides
EA200400777A1 (en) PHARMACEUTICAL COMPOSITIONS PLATINUM CONNECTIONS
PE20001032A1 (en) COMPOSITIONS AND METHODS TO TREAT PULMONARY DISEASES
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BRPI0508540A (en) compound, pharmaceutical composition, and use of a compound
RU2011151468A (en) ARTIFICIAL Tears AND THERAPEUTIC APPLICATIONS
AR039118A1 (en) FOOD BAR TO MAINTAIN THE ALERT STATUS
EA200701750A1 (en) IMPROVED PENOFIBRATE COMPOSITIONS CONTAINING MENTHOL OR PEG / POLOXAMER
US8206759B2 (en) Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
BR0013385A (en) Pharmaceutical compositions for oral and topical administration
EA200400888A1 (en) PHARMACEUTICALALLY ACCEPTABLE TURNS CARRYING GLYCERINE PHOSPHATE
RU2002118730A (en) DRUG FOR LOCAL USE IN TREATMENT OF TUBERCULOSIS OF PULMONARY AND PURULENT INFLAMMATORY DISEASES
IS7311A (en) A pharmaceutical composition comprising cyclosporin and its use
AR033151A1 (en) AGENT FOR THE TOPICAL OPHTHALMIC TREATMENT OF OCULAR INFLAMMATORY DISEASES
ECSP045110A (en) COMPOSITIONS OF THE PREPARATION CONTAINING A PHYSIOLOGICALLY ACTIVE COMPOSITE OF UNSTABLE ACIDS AND PROCESSES FOR THEIR PRODUCTION
NO20013015L (en) Liposomine inflammatory acid - new transdermal anti-inflammatory drug
ATE242626T1 (en) WATER-SOLUBLE PHARMACEUTICAL DOSAGE FORM, EXCLUDING EFFORTABLE FORMS, CONTAINING NON-STEROID ANTI-INFLAMMATORY ACTIVE INGREDIENTS
EA200601839A1 (en) FUNGICIDE MIXTURES
AR053333A1 (en) ORAL AND PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF AROMATIC SOLUBILIZING AGENTS
Raij Mechanisms of vascular injury: the emerging role of the endothelium.
EA200800679A1 (en) ФУНГИЦИДНЫЕ MIXES OF TRIAZOLOV BASES
AR008764A1 (en) HYDRATED SALTS OF N, N'-DIACETILCISTINA, PROCESS FOR ITS PREPARATION, AND THERAPEUTIC COMPOSITIONS THAT INCLUDE SUCH SALTS AS AN ACTIVE INGREDIENT.

Legal Events

Date Code Title Description
PC4A Invention patent assignment

Effective date: 20060213

MM4A The patent is invalid due to non-payment of fees

Effective date: 20100717

RZ4A Other changes in the information about an invention
MM4A The patent is invalid due to non-payment of fees

Effective date: 20150717